Lemonade Form 4: 127,780-Share Option Award to President Wininger
Rhea-AI Filing Summary
Shai Wininger, President and Director of Lemonade, Inc. (LMND), received a grant of stock options covering 127,780 shares with an exercise price of $59.74. The option award was reported as a transaction dated 08/21/2025 and the form was signed on 08/25/2025 by an attorney-in-fact. The filing states the option will vest in 12 equal quarterly installments beginning on 08/18/2025, subject to continued employment, and the option expires on 08/18/2035. After the reported grant, the reporting person beneficially owns 127,780 shares directly attributable to this option position.
Positive
- Grant of 127,780 stock options to the reporting person is explicitly disclosed
- Clear vesting schedule: 12 equal quarterly installments beginning 08/18/2025
- Exercise price stated: $59.74 and expiration date provided (08/18/2035)
Negative
- None.
Insights
TL;DR: Routine executive equity grant aligns management with shareholders but is not a cash compensation event.
The filing documents a non-derivative equity grant in the form of a stock option for 127,780 shares at a $59.74 exercise price. Vesting begins 08/18/2025 over 12 quarterly installments, with an expiration date of 08/18/2035. This is a standard long-term incentive that ties the reporting persons compensation to future share performance. The transaction increases the reporting persons direct beneficial ownership by 127,780 options as reported.
TL;DR: Grant to a President/Director is a common governance practice to promote retention and alignment.
The Form 4 confirms the recipient is both a director and the President, indicating the award is to a senior executive with governance responsibilities. The explicit vesting schedule—12 equal quarterly installments starting 08/18/2025—is a time-based retention schedule. The signature by an attorney-in-fact on 08/25/2025 completes the reporting requirements. The disclosure is clear and follows Section 16 reporting norms.
FAQ
Who reported the transaction on Form 4 for LMND?
What security and amount were reported on the Form 4 for LMND?
What is the exercise price and key dates for the option grant reported?
How many shares does the reporting person beneficially own after this transaction?
Who signed the Form 4 and when was it filed?